These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 21307379)

  • 1. Glomerular and tubular damage markers are elevated in patients with diabetes.
    Nauta FL; Boertien WE; Bakker SJ; van Goor H; van Oeveren W; de Jong PE; Bilo H; Gansevoort RT
    Diabetes Care; 2011 Apr; 34(4):975-81. PubMed ID: 21307379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for early detection of sickle nephropathy.
    Sundaram N; Bennett M; Wilhelm J; Kim MO; Atweh G; Devarajan P; Malik P
    Am J Hematol; 2011 Jul; 86(7):559-66. PubMed ID: 21630304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
    Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
    Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
    Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
    Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
    Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
    Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
    Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of renal tubular damage in chronic heart failure.
    Damman K; Masson S; Hillege HL; Maggioni AP; Voors AA; Opasich C; van Veldhuisen DJ; Montagna L; Cosmi F; Tognoni G; Tavazzi L; Latini R
    Eur Heart J; 2011 Nov; 32(21):2705-12. PubMed ID: 21666249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.
    Fufaa GD; Weil EJ; Nelson RG; Hanson RL; Bonventre JV; Sabbisetti V; Waikar SS; Mifflin TE; Zhang X; Xie D; Hsu CY; Feldman HI; Coresh J; Vasan RS; Kimmel PL; Liu KD;
    Diabetologia; 2015 Jan; 58(1):188-98. PubMed ID: 25316431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
    Nielsen SE; Schjoedt KJ; Astrup AS; Tarnow L; Lajer M; Hansen PR; Parving HH; Rossing P
    Diabet Med; 2010 Oct; 27(10):1144-50. PubMed ID: 20854382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).
    Peralta CA; Katz R; Bonventre JV; Sabbisetti V; Siscovick D; Sarnak M; Shlipak MG
    Am J Kidney Dis; 2012 Dec; 60(6):904-11. PubMed ID: 22749388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical value of NGAL, L-FABP and albuminuria in predicting GFR decline in type 2 diabetes mellitus patients.
    Chou KM; Lee CC; Chen CH; Sun CY
    PLoS One; 2013; 8(1):e54863. PubMed ID: 23349979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
    Nielsen SE; Andersen S; Zdunek D; Hess G; Parving HH; Rossing P
    Kidney Int; 2011 May; 79(10):1113-8. PubMed ID: 21270761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: a cross-sectional analysis.
    Meijer E; Boertien WE; Nauta FL; Bakker SJ; van Oeveren W; Rook M; van der Jagt EJ; van Goor H; Peters DJ; Navis G; de Jong PE; Gansevoort RT
    Am J Kidney Dis; 2010 Nov; 56(5):883-95. PubMed ID: 20888104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
    Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
    Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA; Köttgen A; Coresh J; Astor BC
    Am J Kidney Dis; 2012 Aug; 60(2):233-40. PubMed ID: 22542304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary Kidney Injury Molecules in Children with Iron-Deficiency Anemia.
    Güneş A; Ece A; Aktar F; Tan İ; Söker M; Karabel D; Balık H; Uluca Ü; Şen V; Yolbaş İ
    Med Sci Monit; 2015 Dec; 21():4023-9. PubMed ID: 26697893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary biomarkers of kidney injury are associated with all-cause mortality in the Women's Interagency HIV Study (WIHS).
    Peralta C; Scherzer R; Grunfeld C; Abraham A; Tien P; Devarajan P; Bennett M; Butch A; Anastos K; Cohen M; Nowicki M; Sharma A; Young M; Sarnak M; Parikh C; Shlipak M
    HIV Med; 2014 May; 15(5):291-300. PubMed ID: 24313986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue?
    Pennemans V; Rigo JM; Faes C; Reynders C; Penders J; Swennen Q
    Clin Chem Lab Med; 2013 Sep; 51(9):1795-802. PubMed ID: 23648635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tubular biomarkers to assess progression of diabetic nephropathy.
    Tramonti G; Kanwar YS
    Kidney Int; 2011 May; 79(10):1042-4. PubMed ID: 21527942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.